We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
Price data last checked 108 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B00E0U989K
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 23 July 2013
Similar Products You Might Like
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
£325.00
24 Feb 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia
£325.00
12 Jan 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
£495.00
07 Jan 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
£495.00
15 Feb 2026
98% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
£495.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Metabolomics in the United States
£495.00
07 Jan 2026
95% match
The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean
£325.00
29 Jan 2026
95% match
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
£325.00
26 Mar 2026
95% match
The 2013-2018 Outlook for Irritable Bowel Syndrome (IBS) Therapeutics in the United States
£495.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States
£495.00
23 Jan 2026
95% match
The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean
£325.00
28 Jan 2026
95% match
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
£325.00
20 Apr 2026
95% match
The 2013-2018 Outlook for Drugs in India
£495.00
16 Dec 2025
94% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas
£325.00
14 Jan 2026
94% match
The 2013-2018 Outlook for Cell-Based Assays in the United States
£495.00
09 Jan 2026
94% match
The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean
£325.00
28 Jan 2026
94% match
The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean
£325.00
21 Jan 2026
94% match
The 2013-2018 Outlook for Scale Inhibitors in India
£495.00
09 Jan 2026
94% match
The 2013-2018 Outlook for Chiral Technologies in the United States
£495.00
09 Feb 2026
94% match
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in the United States
£495.00
11 Jan 2026
94% match
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in the United States
£495.00
08 Jan 2026
94% match
The 2013-2018 Outlook for Pipettes and Pipettors in North America & the Caribbean
£325.00
24 Jan 2026
94% match
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
£325.00
31 Mar 2026
94% match
The 2013-2018 Outlook for Itaconic Acid (IA) in North America & the Caribbean
£325.00
24 Jan 2026